iOrganBio
https://iorgan.bio/Research Platforms
iOrganBio is transforming human cell production with CellForge, its AI-powered platform for consistent, scalable, and intelligent manufacturing of cells and organoids for in vitro modeling and cell therapies. By applying engineering precision to biology, CellForge uses AI and automation to guide cell development and make real-time adjustments aligned with defined biological profiles.
Leadership & Board
- Current Number of Employees
- 23
- Current LinkedIn Followers
- 3,607
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $2M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $2M
- Latest Funding Round
- Investment
- Post-Money Valuation
- ―
Employee Trend
iOrganBio had 23 employees as of October 12, 2026. The number of employees increased by 1 (4.55%) week-over-week.
23Latest Employee Count
1(4.55%)Week-Over-Week Change
Social Trend
iOrganBio had 3,607 followers as of October 12, 2026. The number of followers increased by 36 (1.01%) week-over-week.
3,607Latest Followers Count
36(1.01%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 29, 2025 | Investment | $2.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| First Star Ventures | Investment |
| IndieBio | Investment |
| Cape Fear BioCapital | Investment |
| 2ndF | Investment |
| Terasaki Institute | Investment |
| Alix Ventures | Investment |
Similar Companies
A snapshot of private companies similar to iOrganBio, helping you discover and navigate related company profiles.
Related News and Analysis
